الفهرس 
BRONCHIAL ASTHMAOnly 14 pages are availabe for public view
 |  | from | 155 |  |  |
| | | from | 155 | | |
Abstract
Morbidity and mortality from asthma have increased over
the past decade despite improved understanding and significant
advances in medical therapeutics (Janice et al., 1992).
This increase in morbidity and mortility from asthma
increases the benifit of pragmatic trials in bronchial asthma.
The aim of pragmatic trials is to determine the place of a
drug in the management of a disease and improve medical
decision making (Lurie et al., 1991).
The goals of the long term management of asthma is to
find the minimum treatment that control symptoms allow
resumption of normal life, prevent severe attack and death and
control airflow obstruction (Lurie et al., 1991).